These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9561763)

  • 1. Chromatographic purification of human alpha 1 proteinase inhibitor from dissolved Cohn fraction IV-1 paste.
    Chen SX; Hammond DJ; Klos AM; Wood WD; Wydick JE; Lebing WR
    J Chromatogr A; 1998 Mar; 800(2):207-18. PubMed ID: 9561763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification of alpha 1 proteinase inhibitor from human plasma fraction IV-1 by ion exchange chromatography.
    Chen SX; Hammond DJ; Lang JM; Lebing WR
    Vox Sang; 1998; 74(4):232-41. PubMed ID: 9691404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New process for purifying high purity α1-antitrypsin from Cohn Fraction IV by chromatography: A promising method for the better utilization of plasma.
    Huangfu C; Zhang J; Ma Y; Jia J; Lv M; Zhao X; Zhang J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Mar; 1046():156-164. PubMed ID: 28183045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of alpha 1-proteinase inhibitor (human).
    Hein RH; Van Beveren SM; Shearer MA; Coan MH; Brockway WJ
    Eur Respir J Suppl; 1990 Mar; 9():16s-20s. PubMed ID: 2340046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical and biological properties of an alpha 1-antitrypsin concentrate.
    Burnouf T; Constans J; Clerc A; Descamps J; Martinache L; Goudemand M
    Vox Sang; 1987; 52(4):291-7. PubMed ID: 3498260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification and analysis of human alpha1-antitrypsin concentrate by a new immunoaffinity chromatography.
    Zhang X; Hou Y; Ding X; Ye S; Cao H; Wang Z; Du X; Xie YW; Li C
    Prep Biochem Biotechnol; 2014 Oct; 44(7):725-37. PubMed ID: 24279822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and properties of an alpha-1-protease inhibitor concentrate with high specific activity.
    Mattes E; Matthiessen HP; Turecek PL; Schwarz HP
    Vox Sang; 2001 Jul; 81(1):29-36. PubMed ID: 11520413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Large-scale purification of high purity α1-antitrypsin from Cohn Fraction IV with virus inactivation by solvent/detergent and dry-heat treatment.
    Huangfu C; Zhang J; Ma Y; Jia J; Li J; Lv M; Ma X; Zhao X; Zhang J
    Biotechnol Appl Biochem; 2018 May; 65(3):446-454. PubMed ID: 29072333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Large-scale gel filtration chromatography for the production of a solvent/detergent-treated high-purity factor VIII concentrate.
    Dengler T; Stöcker U; Kellner S; Fürst G
    Vox Sang; 1990; 58(4):257-63. PubMed ID: 1697997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Yield improvement for manufacture of alpha-proteinase inhibitor.
    Zimmerman TP
    Vox Sang; 2006 Nov; 91(4):309-15. PubMed ID: 17105606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification of human butyrylcholinesterase from frozen Cohn fraction IV-4 by ion exchange and Hupresin affinity chromatography.
    Schopfer LM; Lockridge O; David E; Hinrichs SH
    PLoS One; 2019; 14(1):e0209795. PubMed ID: 30625168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non enzymatic glycosylation of alpha-1-proteinase inhibitor of human plasma.
    Phadke M; Billimoria FR; Ninjoor V
    J Postgrad Med; 1998; 44(2):29-34. PubMed ID: 10703566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification of alpha 1-proteinase inhibitor by triazine dye affinity chromatography, ion-exchange chromatography and gel filtration on Fractogel TSK.
    Gunzer G; Hennrich N
    J Chromatogr; 1984 Jul; 296():221-9. PubMed ID: 6332820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification of alpha-1-proteinase inhibitor. Preparation and properties of a therapeutic concentrate.
    Coan MH
    Am J Med; 1988 Jun; 84(6A):32-6. PubMed ID: 3260071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developing procedures for the large-scale purification of human serum butyrylcholinesterase.
    Saxena A; Luo C; Doctor BP
    Protein Expr Purif; 2008 Oct; 61(2):191-6. PubMed ID: 18602477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and properties of alpha 1-proteinase inhibitor concentrate from human plasma.
    Coan MH; Brockway WJ; Eguizabal H; Krieg T; Fournel M
    Vox Sang; 1985; 48(6):333-42. PubMed ID: 3874474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterisation and virus safety of alpha 1-proteinase inhibitor.
    Coan MH; Dobkin MB; Brockway WJ; Mitra G
    Eur Respir J Suppl; 1990 Mar; 9():35s-38s. PubMed ID: 2340049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation and characterization of alpha 1-protease inhibitor from canine plasma.
    Melgarejo T; Williams DA; Griffith G
    Am J Vet Res; 1996 Mar; 57(3):258-63. PubMed ID: 8669751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of immobilized methylchymotrypsin for the purification of human and sheep alpha-1-proteinase inhibitor (alpha(1)-PI).
    Grybel J; Wilusz T
    Cell Mol Biol Lett; 2003; 8(2):363-74. PubMed ID: 12813571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation and characterization of alpha-1-proteinase inhibitor from goat plasma.
    Salahuddin P
    Biochem Int; 1991 May; 24(2):321-38. PubMed ID: 1930250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.